Elyxium Wealth’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$330K Sell
5,261
-22
-0.4% -$1.76K 0.11% 124
2025
Q4
$504K Buy
5,283
+221
+4% +$21.7K 0.14% 110
2025
Q3
$494K Sell
5,062
-11
-0.2% -$1.14K 0.17% 99
2025
Q2
$545K Buy
5,073
+84
+2% +$8.5K 0.2% 95
2025
Q1
$503K Buy
4,989
+2,724
+120% +$274K 0.22% 88
2024
Q4
$202K Sell
2,265
-2,375
-51% -$209K 0.12% 86
2024
Q3
$389K Buy
+4,640
New +$366K 0.21% 85

Other funds holding BSX

Elyxium Wealth's BSX Position: Q1 2026 in Review

Elyxium Wealth reduced its Boston Scientific (BSX) stake by 0.42% in Q1 2026, selling an estimated $1.76K and leaving 5,261 shares worth $330K. The position accounts for 0.11% of the portfolio, ranked #124.

Elyxium Wealth first reported a position in BSX in Q3 2024 and has held it in 7 quarters since. The position peaked at $545K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Elyxium Wealth held 5,261 shares of Boston Scientific worth $330K as of Q1 2026.
  • Elyxium Wealth sold 22 Boston Scientific shares in Q1 2026, an estimated $1.76K.
  • Boston Scientific made up 0.11% of Elyxium Wealth's portfolio in Q1 2026, its #124 holding.
  • Elyxium Wealth first reported a position in Boston Scientific in Q3 2024 and has held it in 7 quarters since.
  • Elyxium Wealth's Boston Scientific position peaked at $545K in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Elyxium Wealth's 13F filing for Q1 2026, filed 6 May 2026.